Remove 2026 Remove Competition Remove Sales
article thumbnail

149 Eye-Opening Sales Statistics to Consider in 2022 (By Category)

Spotio

More empowered buyers has resulted in longer sales cycles. And, 50-90% of the journey is complete before a buyer interacts with a sales rep. This shift in behavior should be taken seriously by any sales team, whether inside or out in the field. Here is a list of 130 sales statistics broken out across 20 categories.

Sales 111
article thumbnail

Consequences of the First 10 Drugs Selected for Medicare’s Negotiation Program

PM360

They do not have biosimilar or generic competition available in the market. Over the next few weeks, manufacturers will submit a range of clinical, marketing, sales, pricing, and patient data, and then meet with CMS to discuss submissions later this fall. They do not qualify for any exemption (e.g.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More

PM360

Generic Drug Launches This year could see up to 50 generic drug approvals on brand pharmaceuticals worth more than $20 billion in sales, Casberg noted. billion in sales. The product had sales of roughly $800 million per year. The drug generated $2 billion in sales last year. “We’re

article thumbnail

Merck defends blockbuster Januvia franchise from patent challenge

pharmaphorum

Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug for another few years. That challenged the ‘708 patent – which expires in November 2026 – as well as one other (No.

article thumbnail

Selling POS Systems: 10 Practical Tips for Field Sales Teams

Spotio

Recent research shows that the hardware as a service market (HaaS) should reach $300+ billion in 2026. If your reps don’t actually use said research to contact and convert leads, your company won’t make sales. You can then adjust your department’s sales strategy to suit. More sales in less time.

Sales 52
article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

billion by 2026, according to research by the Business Research Company. If you have to wait to extract meaning from your data then you won’t be competitive enough. “A This dynamic approach can also be used to predict and recommend next-best actions in sales and marketing, while both improving the customer experience and ROI.

article thumbnail

Two Key Questions About Payer Strategies in 2023

PM360

However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. Given the volume of 340B sales (13% of total U.S. Quality and value measurements commonly used outside of the U.S. The 340B battle will rage on.